BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 32385832)

  • 1. Estimation of prevalence of transthyretin (ATTR) cardiac amyloidosis in an Australian subpopulation using bone scans with echocardiography and clinical correlation.
    Cuscaden C; Ramsay SC; Prasad S; Goodwin B; Smith J
    J Nucl Cardiol; 2021 Dec; 28(6):2845-2856. PubMed ID: 32385832
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bone scintigraphy with (99m)technetium-hydroxymethylene diphosphonate allows early diagnosis of cardiac involvement in patients with transthyretin-derived systemic amyloidosis.
    Glaudemans AW; van Rheenen RW; van den Berg MP; Noordzij W; Koole M; Blokzijl H; Dierckx RA; Slart RH; Hazenberg BP
    Amyloid; 2014 Mar; 21(1):35-44. PubMed ID: 24455993
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of (99m)Tc-DPD scintigraphy in diagnosis and prognosis of hereditary transthyretin-related cardiac amyloidosis.
    Rapezzi C; Quarta CC; Guidalotti PL; Pettinato C; Fanti S; Leone O; Ferlini A; Longhi S; Lorenzini M; Reggiani LB; Gagliardi C; Gallo P; Villani C; Salvi F
    JACC Cardiovasc Imaging; 2011 Jun; 4(6):659-70. PubMed ID: 21679902
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimal Echocardiographic Parameters to Improve the Diagnostic Yield of Tc-99m-Bone Avid Tracer Cardiac Scintigraphy for Transthyretin Cardiac Amyloidosis.
    Cuddy SA; Datar Y; Ovsak G; Saith S; Murphy SP; Bay CP; Haddad M; Lilleness B; Muralidhar V; Pipilas A; Vuong J; Guardino E; Maurer MS; Ruberg FL; Falk RH; Dorbala S
    Circ Cardiovasc Imaging; 2022 Nov; 15(11):e014645. PubMed ID: 36378779
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low Sensitivity of Bone Scintigraphy in Detecting Phe64Leu Mutation-Related Transthyretin Cardiac Amyloidosis.
    Musumeci MB; Cappelli F; Russo D; Tini G; Canepa M; Milandri A; Bonfiglioli R; Di Bella G; My F; Luigetti M; Grandis M; Autore C; Perlini S; Perfetto F; Rapezzi C
    JACC Cardiovasc Imaging; 2020 Jun; 13(6):1314-1321. PubMed ID: 31864976
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Utility of
    Moore PT; Burrage MK; Mackenzie E; Law WP; Korczyk D; Mollee P
    Heart Lung Circ; 2017 Nov; 26(11):1183-1190. PubMed ID: 28256403
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pattern of myocardial
    Pradel S; Brun S; Victor G; Pascal P; Fournier P; Ribes D; Lavie-Badie Y; Galinier M; Carrié D; Berry I; Lairez O;
    J Nucl Cardiol; 2020 Feb; 27(1):96-105. PubMed ID: 29881913
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discordant Findings on 18F-NaF and 99mTc-HDP Bone Scans in a Patient With ATTR Cardiac Amyloidosis.
    Ng QKT; Sethi P; Saunders TA; Pampaloni MH; Flavell RR
    Clin Nucl Med; 2018 Mar; 43(3):e89-e92. PubMed ID: 29261619
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiac scintigraphy with
    de Haro-Del Moral FJ; Pubul-Núñez V; Casáns-Tormo I; Jiménez-Heffernan A; Ruano-Pérez R
    Rev Esp Med Nucl Imagen Mol (Engl Ed); 2020; 39(4):254-266. PubMed ID: 32513587
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic performance characteristics of planar quantitative and semi-quantitative parameters of Tc
    Pandey S; Teruya S; Rodriguez C; Deluca A; Kinkhabwala M; Johnson LL; Fine D; Sabogal N; Winburn M; Castillo M; Bhatia K; Malkovskaya R; Raiszadeh F; Kurian D; Miller EJ; Einstein AJ; Maurer MS; Ruberg FL
    J Nucl Cardiol; 2023 Aug; 30(4):1414-1419. PubMed ID: 36823486
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Towards a Diagnosis of Cardiac Amyloidosis: Single Center Experience with
    Saleem M; Sadat B; Van Harn M; Ananthasubramaniam K
    Medicina (Kaunas); 2023 Feb; 59(2):. PubMed ID: 36837580
    [No Abstract]   [Full Text] [Related]  

  • 12. Accuracy of 99mTc-Hydroxymethylene diphosphonate scintigraphy for diagnosis of transthyretin cardiac amyloidosis.
    Cappelli F; Gallini C; Di Mario C; Costanzo EN; Vaggelli L; Tutino F; Ciaccio A; Bartolini S; Angelotti P; Frusconi S; Farsetti S; Vergaro G; Giorgetti A; Marzullo P; Genovesi D; Emdin M; Perfetto F
    J Nucl Cardiol; 2019 Apr; 26(2):497-504. PubMed ID: 28537040
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Apical sparing pattern of left ventricular myocardial
    Van Der Gucht A; Cottereau AS; Abulizi M; Guellich A; Blanc-Durand P; Israel JM; Galat A; Plante-Bordeneuve V; Dubois-Randé JL; Bodez D; Rosso J; Damy T; Itti E
    J Nucl Cardiol; 2018 Dec; 25(6):2072-2079. PubMed ID: 28447284
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of cardiac scintigraphy with ⁹⁹mTc-DPD in the differentiation of cardiac amyloidosis subtype.
    de Haro-del Moral FJ; Sánchez-Lajusticia A; Gómez-Bueno M; García-Pavía P; Salas-Antón C; Segovia-Cubero J
    Rev Esp Cardiol (Engl Ed); 2012 May; 65(5):440-6. PubMed ID: 22464102
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Light Chain Testing Abnormalities Among Patients With Transthyretin Amyloid Cardiomyopathy Referred for Technetium-99m Pyrophosphate Imaging.
    Alreshq R; Cozzolino M; Lilleness B; Pipilas A; Mendelson L; Joshi T; Muralidhar V; Guardino E; Berk JL; Siddiqi OK; Gopal DM; Sanchorawala V; Ruberg FL
    Am J Cardiol; 2022 Oct; 181():105-112. PubMed ID: 36028388
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inter-observer reproducibility and intra-observer repeatability in
    Singh V; Cuddy S; Kijewski MF; Park MA; Taylor A; Taqueti VR; Skali H; Blankstein R; Falk RH; Di Carli MF; Dorbala S
    J Nucl Cardiol; 2022 Apr; 29(2):440-446. PubMed ID: 32918247
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multicenter Study of Planar Technetium 99m Pyrophosphate Cardiac Imaging: Predicting Survival for Patients With ATTR Cardiac Amyloidosis.
    Castano A; Haq M; Narotsky DL; Goldsmith J; Weinberg RL; Morgenstern R; Pozniakoff T; Ruberg FL; Miller EJ; Berk JL; Dispenzieri A; Grogan M; Johnson G; Bokhari S; Maurer MS
    JAMA Cardiol; 2016 Nov; 1(8):880-889. PubMed ID: 27557400
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Usefulness of (99m)Tc-HMDP scintigraphy for the etiologic diagnosis and prognosis of cardiac amyloidosis.
    Galat A; Rosso J; Guellich A; Van Der Gucht A; Rappeneau S; Bodez D; Guendouz S; Tissot CM; Hittinger L; Dubois-Randé JL; Plante-Bordeneuve V; Itti E; Meignan M; Damy T
    Amyloid; 2015; 22(4):210-20. PubMed ID: 26465835
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pulmonary 99mTc-HMDP uptake correlates with restrictive ventilatory defects and abnormal lung reactance in transthyretin cardiac amyloidosis patients.
    Monfort A; Rivas A; Banydeen R; Inamo J; Farid K; Neviere R
    Respir Res; 2022 Mar; 23(1):72. PubMed ID: 35346209
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early-phase myocardial uptake intensity of
    Abulizi M; Cottereau AS; Guellich A; Vandeventer S; Galat A; Van Der Gucht A; Plante-Bordeneuve V; Dubois-Randé JL; Bodez D; Rosso J; Damy T; Itti E
    J Nucl Cardiol; 2018 Feb; 25(1):217-222. PubMed ID: 27804073
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.